Literature DB >> 15149740

Changing concepts in the surgical management of renal cell carcinoma.

John S Lam1, Oleg Shvarts, Allan J Pantuck.   

Abstract

The foundations of the generally accepted principles underlying the surgical management of renal cell carcinoma (RCC) were best annunciated in 1969 by Robson in his classic description of the radical nephrectomy [J Urol 1969;101;297]. Since then, much has changed in our understanding of the basic biology and genetics of kidney cancer, advances in renal imaging and clinical staging have led to the increased detection of incidental, lower stage, organ-confined tumors more amendable to expanded surgical options, surgical techniques themselves have evolved, and surgical equipment technology has advanced to make possible new methods of managing renal tumors in situ. Thus, the management of both localized and metastatic RCC has changed dramatically in the last 20 years, predicated on these major advancements in renal imaging, surgical techniques, and the development of effective immunotherapies for advanced disease. In this review, the evolution in thinking regarding the tenets of the radical nephrectomy will be examined, including the necessity for removal of the entire kidney, the possibility of sparing the adrenal gland, when and how extensive a lymphadenectomy should be performed, the development of laparoscopic and percutaneous nephron-sparing surgery using ablative technologies, and the role of nephrectomy and metastasectomy in patients with metastatic RCC. Here, we review current concepts and outcomes on the surgical management of RCC to help elucidate some of these changes, from the evolution of open to laparoscopic to percutaneous, from radical to partial to ablative approaches.

Entities:  

Mesh:

Year:  2004        PMID: 15149740     DOI: 10.1016/j.eururo.2004.02.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  29 in total

Review 1.  Laparoscopic radical and partial nephrectomy: technical issues and outcome.

Authors:  Evangelos Liatsikos; Panagiotis Kallidonis; Minh Do; Anja Dietel; Abdulrahman Al-Aown; Constantinos Constantinidis; Jens-Uwe Stolzenburg
Journal:  World J Urol       Date:  2011-11-26       Impact factor: 4.226

2.  The laparoscopic nephrectomy learning curve: a single centre's development of a de novo practice.

Authors:  J Phillips; J W F Catto; V Lavin; D Doyle; D J Smith; K J Hastie; N E Oakley
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  Utilization of interventional oncology treatments in the United States.

Authors:  Sharon W Kwan; Robert K Kerlan; Jonathan H Sunshine
Journal:  J Vasc Interv Radiol       Date:  2010-05-15       Impact factor: 3.464

4.  Renal cell carcinoma with t(X;17)(p11.2;q25) in a 5-year-old Taiwanese boy: a case report and review of the literature.

Authors:  Chih-Jung Chen; Hui-Ting Hsu; Ming-Tsan Lin; Mariann Pintye; Jim-Ray Chen
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

5.  [Small renal mass].

Authors:  D Prokofiev; N Kreutzer; A Kress; F Wissing; H Pfeifer; J-U Stolzenburg; A Dietel; T Schwalenberg; M Do; M C Truß
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

6.  Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.

Authors:  Keiichi Ito; Shigeyoshi Soga; Kenji Seguchi; Yusuke Shinchi; Ayako Masunaga; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Hiroshi Shinmoto; Tatsumi Kaji; Tomohiko Asano
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

7.  Diagnostic utility of diffusion-weighted magnetic resonance imaging in two common renal tumors.

Authors:  Zhaoxia Wen; Zhenchao Sun; Yuxing Wang
Journal:  Oncol Lett       Date:  2015-08-13       Impact factor: 2.967

8.  Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.

Authors:  Christina A von Roemeling; Derek C Radisky; Laura A Marlow; Simon J Cooper; Stefan K Grebe; Panagiotis Z Anastasiadis; Han W Tun; John A Copland
Journal:  Cancer Res       Date:  2014-06-24       Impact factor: 12.701

Review 9.  [Energy ablative therapy of renal tumours].

Authors:  H C Klingler
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

10.  Retroperitoneal laparoscopic radical nephrectomy: intermediate oncological results.

Authors:  Stéphane Larré; Chaker Kanso; Alexandre De La Taille; Andras Hoznek; Dimitrios Vordos; René Yiou; Clément-Claude Abbou; Laurent Salomon
Journal:  World J Urol       Date:  2008-07-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.